Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 16, 2022
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
[ Wed, Feb 16th 2022
] - WOPRAI
Roanna Ruiz Maintained (XERS) at Buy with Decreased Target to $6 on, Feb 16th, 2022
Roanna Ruiz of SVB Leerink, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Buy with Decreased Target from $8 to $6 on, Feb 16th, 2022.
Roanna has made no other calls on XERS in the last 4 months.
There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Roanna's Rating of Hold.
This is the rating of the analyst that currently disagrees with Roanna
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5.4 on, Friday, December 31st, 2021
